SPALLAROSSA, PAOLO
SPALLAROSSA, PAOLO
100007 - Dipartimento di Medicina interna e specialità mediche
Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions.
2014-01-01 Ghigliotti, Giorgio; Barisione, Chiara; Garibaldi, Silvano; Fabbi, Patrizia; Brunelli, Claudio; Spallarossa, Paolo; Altieri, Paola; Rosa, Gianmarco; Spinella, GIOVANNI SALVATORE GIUSEPPE; Palombo, Domenico; Arsenescu, Razvan; Arsenescu, Violeta
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice
2021-01-01 Tini, G.; Cuomo, A.; Battistoni, A.; Sarocchi, M.; Mercurio, V.; Ameri, P.; Volpe, M.; Porto, I.; Tocchetti, C. G.; Spallarossa, P.
Cancer Patient With Unusual Dyspnea in the COVID-19 Era
2021-01-01 La Malfa, Giovanni; Spallarossa, Paolo; Tini, Giacomo; Sarocchi, Matteo; Salsano, Antonio; Parolari, Giulia; Guadagno, Antonio; Sciallero, Stefania; Porto, Italo; Santini, Francesco
Cardiovascular safety of the tyrosine kinase inhibitor nintedanib
2021-01-01 Ameri, Pietro; Tini, Giacomo; Spallarossa, Paolo; Mercurio, Valentina; Tocchetti, Carlo Gabriele; Porto, Italo
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
2023-01-01 Masini, M.; Toma, M.; Spallarossa, P.; Porto, I.; Ameri, P.
Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer
2021-01-01 TINI MELATO, Giacomo; Ameri, Pietro; Buzzatti, Giulia; Sarocchi, Matteo; Murialdo, Roberto; Guglielmi, Giulia; Arboscello, Eleonora; Ballestrero, Alberto; DEL MASTRO, Lucia; Spallarossa, Paolo; Porto, Italo
Does the HFA/ICOS tool overestimate the risk of cardiovascular toxicities in oncologic patients scheduled to receive anti-VEGF agents?
2022-01-01 Tini, Giacomo; Sarocchi, Matteo; Ameri, Pietro; Tocci, Giuliano; Battistoni, Allegra; Arboscello, Eleonora; Spallarossa, Paolo; Porto, Italo
Engineering for Biomedical Sector: A Cross-Industry Approach for the Analysis of Molecular Patterns behind Endothelial Damage Related to Leukemia Therapy
2024-01-01 Ferrari, PIER FRANCESCO; Pettinato, Margherita; Bergamaschi, Micaela; Perego, Patrizia; Spallarossa, Paolo; Arboscello, Eleonora; Lemoli, ROBERTO MASSIMO; Bagnato, Paola; Pratesi, Giovanni; Palombo, Domenico; Fabiano, Bruno
How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy
2020-01-01 Spallarossa, P.; Sarocchi, M.; Tini, G.; Arboscello, E.; Toma, M.; Ameri, P.; Porto, I.
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature
2023-01-01 Boutros, A; Bottini, A; Rossi, G; Tanda, E T; Spagnolo, F; Barletta, G; Croce, E; Fava, P; Parisi, A; De Rosa, F; Palla, M; Marconcini, R; Ferrari, M; Grandis, M; Spallarossa, P; Sarocchi, M; Arboscello, E; Del Mastro, L; Lambertini, M; Pronzato, P; Genova, C
Patterns of anticoagulation for atrial fibrillation in cancer patients referred to cardio-oncological evaluation
2020-01-01 Toma, M.; Rrapaj, E.; Spallarossa, P.; Guerra, F.; Ameri, P.
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects
2018-01-01 Spallarossa, Paolo; Meliota, Giovanni; Brunelli, Claudio; Arboscello, Eleonora; Ameri, Pietro; Dessalvi, Christian Cadeddu; Grossi, Francesco; Deidda, Martino; Mele, Donato; Sarocchi, Matteo; Bellodi, Andrea; Madonna, Rosalinda; Mercuro, Giuseppe
Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease.
2016-01-01 Balestrino, Maurizio; Sarocchi, Matteo; Adriano, ENRICO GIOVANNI; Spallarossa, Paolo
Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms
2016-01-01 Barisione, Chiara; Garibaldi, Silvano; Brunelli, Claudio; Balbi, Manrico; Spallarossa, Paolo; Canepa, Marco; Ameri, Pietro; Viazzi, FRANCESCA CHIARA; Verzola, Daniela; Lorenzoni, Alessandra; Baldassini, Riccardo; Palombo, Domenico; Pane, Bianca; Spinella, GIOVANNI SALVATORE GIUSEPPE; Ghigliotti, Giorgio
Redox imbalances in ageing and metabolic alterations: Implications in cancer and cardiac diseases. An overview from the working group of cardiotoxicity and cardioprotection of the Italian society of cardiology (SIC)
2020-01-01 Mercurio, V.; Cuomo, A.; Dessalvi, C. C.; Deidda, M.; Di Lisi, D.; Novo, G.; Manganaro, R.; Zito, C.; Santoro, C.; Ameri, P.; Spallarossa, P.; Arboscello, E.; Tocchetti, C. G.; Penna, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. | 1-gen-2014 | Ghigliotti, Giorgio; Barisione, Chiara; Garibaldi, Silvano; Fabbi, Patrizia; Brunelli, Claudio; Spallarossa, Paolo; Altieri, Paola; Rosa, Gianmarco; Spinella, GIOVANNI SALVATORE GIUSEPPE; Palombo, Domenico; Arsenescu, Razvan; Arsenescu, Violeta | |
| Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice | 1-gen-2021 | Tini, G.; Cuomo, A.; Battistoni, A.; Sarocchi, M.; Mercurio, V.; Ameri, P.; Volpe, M.; Porto, I.; Tocchetti, C. G.; Spallarossa, P. | |
| Cancer Patient With Unusual Dyspnea in the COVID-19 Era | 1-gen-2021 | La Malfa, Giovanni; Spallarossa, Paolo; Tini, Giacomo; Sarocchi, Matteo; Salsano, Antonio; Parolari, Giulia; Guadagno, Antonio; Sciallero, Stefania; Porto, Italo; Santini, Francesco | |
| Cardiovascular safety of the tyrosine kinase inhibitor nintedanib | 1-gen-2021 | Ameri, Pietro; Tini, Giacomo; Spallarossa, Paolo; Mercurio, Valentina; Tocchetti, Carlo Gabriele; Porto, Italo | |
| Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism | 1-gen-2023 | Masini, M.; Toma, M.; Spallarossa, P.; Porto, I.; Ameri, P. | |
| Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer | 1-gen-2021 | TINI MELATO, Giacomo; Ameri, Pietro; Buzzatti, Giulia; Sarocchi, Matteo; Murialdo, Roberto; Guglielmi, Giulia; Arboscello, Eleonora; Ballestrero, Alberto; DEL MASTRO, Lucia; Spallarossa, Paolo; Porto, Italo | |
| Does the HFA/ICOS tool overestimate the risk of cardiovascular toxicities in oncologic patients scheduled to receive anti-VEGF agents? | 1-gen-2022 | Tini, Giacomo; Sarocchi, Matteo; Ameri, Pietro; Tocci, Giuliano; Battistoni, Allegra; Arboscello, Eleonora; Spallarossa, Paolo; Porto, Italo | |
| Engineering for Biomedical Sector: A Cross-Industry Approach for the Analysis of Molecular Patterns behind Endothelial Damage Related to Leukemia Therapy | 1-gen-2024 | Ferrari, PIER FRANCESCO; Pettinato, Margherita; Bergamaschi, Micaela; Perego, Patrizia; Spallarossa, Paolo; Arboscello, Eleonora; Lemoli, ROBERTO MASSIMO; Bagnato, Paola; Pratesi, Giovanni; Palombo, Domenico; Fabiano, Bruno | |
| How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy | 1-gen-2020 | Spallarossa, P.; Sarocchi, M.; Tini, G.; Arboscello, E.; Toma, M.; Ameri, P.; Porto, I. | |
| Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature | 1-gen-2023 | Boutros, A; Bottini, A; Rossi, G; Tanda, E T; Spagnolo, F; Barletta, G; Croce, E; Fava, P; Parisi, A; De Rosa, F; Palla, M; Marconcini, R; Ferrari, M; Grandis, M; Spallarossa, P; Sarocchi, M; Arboscello, E; Del Mastro, L; Lambertini, M; Pronzato, P; Genova, C | |
| Patterns of anticoagulation for atrial fibrillation in cancer patients referred to cardio-oncological evaluation | 1-gen-2020 | Toma, M.; Rrapaj, E.; Spallarossa, P.; Guerra, F.; Ameri, P. | |
| Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects | 1-gen-2018 | Spallarossa, Paolo; Meliota, Giovanni; Brunelli, Claudio; Arboscello, Eleonora; Ameri, Pietro; Dessalvi, Christian Cadeddu; Grossi, Francesco; Deidda, Martino; Mele, Donato; Sarocchi, Matteo; Bellodi, Andrea; Madonna, Rosalinda; Mercuro, Giuseppe | |
| Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease. | 1-gen-2016 | Balestrino, Maurizio; Sarocchi, Matteo; Adriano, ENRICO GIOVANNI; Spallarossa, Paolo | |
| Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms | 1-gen-2016 | Barisione, Chiara; Garibaldi, Silvano; Brunelli, Claudio; Balbi, Manrico; Spallarossa, Paolo; Canepa, Marco; Ameri, Pietro; Viazzi, FRANCESCA CHIARA; Verzola, Daniela; Lorenzoni, Alessandra; Baldassini, Riccardo; Palombo, Domenico; Pane, Bianca; Spinella, GIOVANNI SALVATORE GIUSEPPE; Ghigliotti, Giorgio | |
| Redox imbalances in ageing and metabolic alterations: Implications in cancer and cardiac diseases. An overview from the working group of cardiotoxicity and cardioprotection of the Italian society of cardiology (SIC) | 1-gen-2020 | Mercurio, V.; Cuomo, A.; Dessalvi, C. C.; Deidda, M.; Di Lisi, D.; Novo, G.; Manganaro, R.; Zito, C.; Santoro, C.; Ameri, P.; Spallarossa, P.; Arboscello, E.; Tocchetti, C. G.; Penna, C. |